Book Details
Orange Code:54895
Paperback:636 pages
Publications:
Categories:
Sections:
1. Glial Modulators as Potential Treatments of Psychostimulant Abuse2. The Vesicular Monoamine Transporter-2: An Important Pharmacological Target for the Discovery of Novel Therapeutics to Treat Methamphetamine Abuse3. Customizing Monoclonal Antibodies for the Treatment of Methamphetamine Abuse: Current and Future Applications4. Monoamine Transporter Inhibitors and Substrates as Treatments for Stimulant Abuse5. Bupropion and Bupropion Analogs as Treatments for CNS Disorders6. The Role of Guanfacine as a Therapeutic Agent to Address Stress-Related Pathophysiology in Cocaine-Dependent Individuals7. Beyond Small-Molecule SAR: Using the Dopamine D3 Receptor Crystal Structure to Guide Drug Design8. Dopamine D4 Receptors in Psychostimulant Addiction9. Sigma (s) Receptors as Potential Therapeutic Targets to Mitigate Psychostimulant Effects10. Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence11. The Combination of Metyrapone and Oxazepam for the Treatment of Cocaine and Other Drug Addictions12. Salvinorin A Analogs and Other Kappa-Opioid Receptor Compounds as Treatments for Cocaine Abuse13. Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse14. New Directions in Nicotine Vaccine Design and Use15. Bath Salts, Mephedrone, and Methylenedioxypyrovalerone as Emerging Illicit Drugs That Will Need Targeted Therapeutic Intervention
Description:
This new volume of Advances in Pharmacology presents the emerging targets and therapeutics in the treatment of psychostimulant abuse. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.
- Contributions from the best authors in the field
- An essential resource for pharmacologists, immunologists, and biochemists
|